WaiChow MD - Astrana Health Chief Officer
AMEHDelisted Stock | USD 34.07 0.34 0.99% |
Insider
WaiChow MD is Chief Officer of Astrana Health
Age | 77 |
Phone | 626 282 0288 |
Web | https://www.apollomed.net |
Astrana Health Management Efficiency
The company has return on total asset (ROA) of 0.0626 % which means that it generated a profit of $0.0626 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0976 %, meaning that it created $0.0976 on every $100 dollars invested by stockholders. Astrana Health's management efficiency ratios could be used to measure how well Astrana Health manages its routine affairs as well as how well it operates its assets and liabilities.Astrana Health currently holds 229.36 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Astrana Health has a current ratio of 2.44, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Astrana Health's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
JD Kennedy | InnovAge Holding Corp | 63 | |
Maria Lozzano | InnovAge Holding Corp | 44 | |
Warren Gouk | Lifestance Health Group | N/A | |
Rusty Yeager | Encompass Health Corp | N/A | |
Kevin Mullins | Lifestance Health Group | 39 | |
Kendra Kimmons | Amedisys | N/A | |
Mark Miller | Encompass Health Corp | N/A | |
Denise Bohnert | Amedisys | 46 | |
John Nugent | Amedisys | N/A | |
Matthew Peterson | Universal Health Services | 54 | |
Dan Peoples | Enhabit | N/A | |
BS MA | Enhabit | 56 | |
Christopher Hunter | Acadia Healthcare | 56 | |
Mike Bavaro | Option Care Health | N/A | |
Pablo Pantaleoni | Lifestance Health Group | 35 | |
Ryan Kubota | InnovAge Holding Corp | N/A | |
Crissy Carlisle | Enhabit | 52 | |
David Bourdon | Lifestance Health Group | 54 | |
Andrew Brophy | Healthcare Services Group | 34 | |
Kevin Connor | Encompass Health Corp | 53 | |
RN MHA | InnovAge Holding Corp | 73 |
Management Performance
Return On Equity | 0.0976 | |||
Return On Asset | 0.0626 |
Astrana Health Leadership Team
Elected by the shareholders, the Astrana Health's board of directors comprises two types of representatives: Astrana Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Astrana. The board's role is to monitor Astrana Health's management team and ensure that shareholders' interests are well served. Astrana Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Astrana Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
WaiChow MD, Chief Officer | ||
Yubin Park, Chief Officer | ||
Dinesh MD, Chief Officer | ||
Neil Ahuja, President Solutions | ||
John Vong, Chief Officer | ||
Kenneth MD, Executive Chairman | ||
Carlos MD, Chief Texas | ||
Chandan Basho, CFO Officer | ||
Jeremy MD, Chief Officer | ||
Brandon Sim, CoChief Officer | ||
Chan Basho, Chief CFO | ||
MPH MD, CoCEO President |
Astrana Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Astrana Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0976 | |||
Return On Asset | 0.0626 | |||
Profit Margin | 0.03 % | |||
Operating Margin | 0.11 % | |||
Current Valuation | 1.81 B | |||
Shares Outstanding | 45.45 M | |||
Shares Owned By Insiders | 25.77 % | |||
Shares Owned By Institutions | 46.99 % | |||
Number Of Shares Shorted | 2.75 M | |||
Price To Earning | 28.18 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Astrana Stock
If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |